Mitrade Insights is dedicated to providing investors with rich, timely and most valuable financial information to help investors grasp the market situation and find timely trading opportunities.

2021

Best News & Analysis Provider

FxDailyInfo

2022

Best Forex Educational Resources Global

International Business Magazine

Insights

News

HSBC upgrades Merck stock to Buy on 2025 opportunities

Source Investing

Investing.com -- HSBC (LON:HSBA) analysts raised their rating on Merck &Company Inc (NYSE:MRK) shares to Buy from Hold while maintaining a price target of $130.

The move comes amid a growing market confidence in the company’s ability to navigate through upcoming patent expirations. Merck (NS:PROR)'s credible strategy for dealing with the loss of exclusivity (LOEs) for key drugs later in the decade has been a contributing factor to the upgrade.

Merck's expertise in oncology and a rich clinical pipeline are seen as key strengths. The company's success in developing cancer treatments, particularly in the field of oncology, has been well-documented.

However, HSBC notes that the true value of Merck's pipeline is expected to be recognized only when early evidence of clinical success emerges, which is not yet reflected in current estimates and stock multiples.

One of the main opportunities identified for Merck in 2025 is the stabilization of Gardasil revenues in China, updates on subcutaneous Keytruda, and the launch trajectory of Winrevir.

“There is a dearth of significant readouts for Merck’s pipeline for 2025 that could change the trajectory of growth,” HSBC analysts said in a report.

“However, updates on Phase II Antibody-Drug Conjugates (ADC) assets might help the market appreciate the potential of these pipeline assets whilst including them in valuation and estimates,” they added.

Key risks for Merck in 2025, according to HSBC, include any signs of Gardasil's growth slowing in developed markets and challenges with the subcutaneous version of Keytruda. If these materialize, they could cast doubt on the market's expectation that Keytruda's patent cliff will level off rather than decline sharply.

The investment bank has adjusted its estimates for Merck downward to account for lower growth potential in Gardasil, particularly regarding its adoption in second-tier Chinese cities and among males.

Even with these revised estimates, HSBC believes that Merck's current valuation offers a significant margin of safety, “especially given its strategy to extend its oncology portfolio’s earning potential in the medium term,” analysts noted.

Looking ahead to the first half of 2025, the bank notes that there may be few clinical catalysts capable of significantly changing Merck's equity story. Nonetheless, Keytruda combination clinical trials could help the company maintain its volume and revenue share in the immuno-oncology market.

Disclaimer: For information purposes only. Past performance is not indicative of future results.

Recommended Articles

Fed hike odds near 90% into Wednesday's decision — how to trade the dollar, gold and the S&P 500 A 0.3% monthly core CPI print has lifted the market-implied probability of a 25bp Fed hike on 16 September to roughly 86.5% ~ 90%, which would be the first increase since July 2023. Here is the decision timeline, the pricing versus the forecasts, both scenarios, and the key levels for the dollar, gold and the S&P 500.

Author Suzie

Sep 14, Mon

A 0.3% monthly core CPI print has lifted the market-implied probability of a 25bp Fed hike on 16 September to roughly 86.5% ~ 90%, which would be the first increase since July 2023. Here is the decision timeline, the pricing versus the forecasts, both scenarios, and the key levels for the dollar, gold and the S&P 500.

Silver breaks $64 as precious metals rebound — can gold hold the $4,280 line into the Fed decision?Silver has climbed back above $64 an ounce for the first time this week, leading a broad rebound across precious metals hours before the Federal Reserve delivers what is expected to be its first rate hike since 2023. Spot silver was last at $64.64, up 1.49% on the day, while gold reclaimed $4,300 and platinum and palladium both advanced. The question now is whether the bounce is a genuine turn — or a pause before the Fed's dot plot decides the next move.

Author Suzie

Sep 16, Wed

Silver has climbed back above $64 an ounce for the first time this week, leading a broad rebound across precious metals hours before the Federal Reserve delivers what is expected to be its first rate hike since 2023. Spot silver was last at $64.64, up 1.49% on the day, while gold reclaimed $4,300 and platinum and palladium both advanced. The question now is whether the bounce is a genuine turn — or a pause before the Fed's dot plot decides the next move.

Bitcoin falls below $75,000 as the CLARITY Act fails in the Senate — what the vote means for crypto The US Senate blocked the Digital Asset Market CLARITY Act in a 49-50 procedural vote, sending Bitcoin briefly below $75,000 — its biggest one-day drop since June. Ethereum fell more than 8%, Coinbase slid 10% and $75 billion of crypto market value evaporated. Here is what the vote was, why it failed, and the levels that matter now.

Author Suzie

Sep 16, Wed

The US Senate blocked the Digital Asset Market CLARITY Act in a 49-50 procedural vote, sending Bitcoin briefly below $75,000 — its biggest one-day drop since June. Ethereum fell more than 8%, Coinbase slid 10% and $75 billion of crypto market value evaporated. Here is what the vote was, why it failed, and the levels that matter now.

Dow drops 631 points as the Fed hikes — but futures are rebounding: what's next for US stocks?The Dow fell 631 points and the S&P 500 closed below 7,600 after the Fed hiked rates for the first time since 2023, with the dot plot showing 16 of 18 officials expect more tightening. Asia-session futures are already recovering — here are the levels and analyst views that decide whether 7,500 holds.

Author Irene Q.

23 hours ago

The Dow fell 631 points and the S&P 500 closed below 7,600 after the Fed hiked rates for the first time since 2023, with the dot plot showing 16 of 18 officials expect more tightening. Asia-session futures are already recovering — here are the levels and analyst views that decide whether 7,500 holds.

Dollar index tops 100 for the first time since July as the Fed's hawkish dot plot sinks in The U.S. dollar index broke back above 100 for the first time since 31 July after the Fed delivered its first rate hike since 2023, with the dot plot showing 16 of 18 officials expect at least one more increase this year. Here are the levels that matter for DXY, the currencies feeling it most, and what to watch next.

Author Irene Q.

23 hours ago

The U.S. dollar index broke back above 100 for the first time since 31 July after the Fed delivered its first rate hike since 2023, with the dot plot showing 16 of 18 officials expect at least one more increase this year. Here are the levels that matter for DXY, the currencies feeling it most, and what to watch next.

Popular Symbols